US Biomax, Inc.
 

Tissue Array and Tissue Microarray from US Biomax

More than 2566 types of tissue array or tissue microarray to choose from.


Tissue Arrays (Microarrays)

Tissue array or tissue microarray from US Biomax includes normal, malignant or metastatic formats. Tissue arrays and Tissue microarrays can be used to validate clinical relevance of potential biological targets in the development of diagnostics, therapeutics and study new protein markers and genes. Tissue arrays (tissue microarrays or tissue-chips) contain protein, RNA, or DNA molecules, thus provides high throughput platforms for the rapid analysis of molecular markers associated with disease diagnosis, prognosis and therapeutics in patients. US Biomax also provides custom tissue array as well as services of immunohistochemistry (IHC) staining and In situ hybridization (ISH) on tissue array or tissue microarray.

Tissue arrays are listed by organ types on the left panel of this page.

Our customers come from a variety of places, including happy customers from NIH, big pharmaceuticals, such as Merck Co., Roche, GSK, Novartis, Genentech, Biogen IDC, etc, big vendors, such as Fisher Scientific and VWR and almost all major universities and research institutions in the United States, not mentioning our strong distribution channels all over the world. We dare to say that tissue arrays from US Biomax have the highest quality in the industry and maintain the most stringent standards on quality controls. US Biomax has been staying at the forefront to maintain the most varieties and quantities of tissue arrays.

Featured US Biomax tissue arrays:

Most viewed tissue microarrays (Hits):

BR1001, Breast cancer tissue array with matched carcinoma metastasis to lymph nodes, 50 cases/100 cores, replaced by BR1004
LC6161, High-density lung cancer array, with stage, grade and normal lung tissue, 322 cases/616 cores
BR6161, High-density breast cancer tissue array, with stage, grade and normal breast tissue, 322 cases/616 cores
ST961, Stomach adenocarcinoma tissue array, including TNM and pathology grade, 48 cases/96 cores
FDA999b, Multiple organ normal tissue array, 47 cases/99 cores, replaced by FDA999c
PR953, Prostate cancer tissue array with matched normal adjacent tissue and metastatic bones, with TNM, Gleason scores, PSA level and survival data, 40 cases/95 cores, replaced by PR954
TP242, Top 4 types of cancer (colon, breast, prostate and lung) 24 core test tissue array, 24 cases/24 cores, replaced by TP242a
OR2081, Oral cavity disease spectrum (oral cancer progression) tissue array, 98 cases/208 cores
BR805, Breast infiltrating lobular carcinoma tissue array, 80 cases/80 cores
BR1003, Breast pre-cancerous disease and cancer tissue array (100 cases/101 cores), with clinical stage and pathology grade data
FDA901, FDA Standard Frozen Tissue Array, for therapeutic and diagnostic antibody validation for FDA approval, total 30 organs, 3 individual donors per organ, spanning two frozen tissue microarray slides.
GL803, Brain tumor tissue array of glioblastoma, astrocytoma, ependymoma, oligo astrocytoma, medulloblastoma and oligodendroglioma, 78 cases/80 cores, replaced by GL803a
ME1004a, Malignant melanoma, metastatic malignant melanoma and nevus tissue array, including TNM and clinical stage, 100 cases/100 cores, replaced by ME1004b
BN04011, Normal lung tissue (multi-sites) tissue array, 22 cases/63 cores, replaced by LC725
BRC961, Breast cancer array with normal and other non-malignant breast tissues, non-overlapping with BRC962, with AR/ER/PR/Her-2(neu) IHC results, 48 cases/96 cores
BM482, Multiple myeloma tissue microarray with normal tissue as control, 24 cases/48 cores, replaced by BM483a
MC803, Retinoblastoma, nephroblastoma, neuroblastoma and leukemia tissue array, 40 cases/80 cores, replaced by MC803a
BR1503a, Breast cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases/150 cores, with IHC results of Her-2, ER, PR, AR, P53 and Ki67, 75 cases/150 cores, replaced by BR1503b
BCC38218, Metastatic malignant melanoma tissue array, 50 cases/100 cores
LY6161, High-density lymphoma and normal lymph node tissue array, 322 cases/616 cores

Newly added tissue microarrays in recent month:

2017-01-24 T301a, Heart tumor tissue array, with normal heart tissue, including TNM, 6 cases/24 cores, replacing T301
2017-01-22 LC817a, Lung cancer with matched lymph node metastasis tissue array, including TNM and pathology grade, 40 cases/80 cores, replacing LC817
2017-01-22 BR501, Breast cancer tissue array, including TNM and pathology grade, 50 cases/ 50 cores
2017-01-22 MY801, Mesentery primarily malignant tumor tissue array, 40 cases/80 cores
2017-01-22 LC2164, Non-small cell lung cancer tissue array (all samples are from 2006 to 2012), including TNM and pathology grade, 108 cases/216 cores
2017-01-20 LC2163, Non-small cell lung cancer tissue array (all samples are from 2006 to 2012), including TNM and pathology grade, 108 cases/216 cores
2017-01-16 OV241c, Ovary cancer with adjacent normal ovary tissue array, including TNM and pathology grade, 12 cases/24 cores, replacing OV241b
2017-01-16 BC05002b, Colon disease spectrum tissue array, including TNM, clinical stage and pathology grade, 79 cases/80 cores,replacing BC05002a
2017-01-16 BS17016b, Brain glioblastoma tissue array, including pathology grade, 40 cases/80 cores, replacing BS17016a
2017-01-13 OV1005b, Ovary disease spectrum (ovarian cancer progression) tissue array, including TNM, clinical stage and pathology grade, 100 cases/100 cores, replacing OV1005a
2017-01-12 BC17012c, Medulloblastoma of brain tissue array with normal tissue as control, 23 cases/ 63 cores, replacing BC17012c
2017-01-11 LC2162, Non-small cell lung cancer tissue array (all samples are from 2006 to 2012), including TNM and pathology grade, 108 cases/216 cores
2016-12-28 FOV401, Ovarian adenocarcinoma frozen tissue array with cancer adjacent tissue as control, including pathology grade, 20 cases/40 cores
2016-12-19 LV803a, Liver carcinoma (combination of adjacent normal, cancer and cancer adjacent tissue), including TNM and pathology grade, 54cases/ 72 cores, replacing LV803
2016-12-06 BR487d, Triple negative breast cancer tissue array, including TNM and pathology grade, 48 cases/48 cores, replacing BR487c
2016-12-05 BR2082b, Breast disease spectrum (breast cancer progression) tissue array, including TNM and pathology grade, 192 cases/192 cores, replacing BR2082a
2016-12-02 BR1505d, Breast cancer tissue array, including TNM, clinical stage and pathology grade, ER/PR/HER2 by IHC, 75 cases/150 cores, replacing BR1505c
2016-11-29 PR482b, Prostate cancer with normal prostate tissue array, including TNM, pathology grade and gleason score, 24cases/48 cores, replacing PR482a
2016-11-29 PA483d, Pancreas cancer tissue array with normal tissue, including TNM and pathology grade, 48 cases/48 cores, replacing PA483c
2016-11-28 HLugA090Ly02, Lung adenocarcinoma tissue microarray, 30 cases. Contains tumor, matched normal adjacent tissue, and matched positive lymph node.